Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

PropertyValue
has major subject area list Antineoplastic Agents; Doxorubicin; Melanoma
has minor subject area list Aged; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome
information resource reference Ellerhorst JA, Bedikian A, Ring S, Buzaid AC, Eton O, Legha SS. Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy. Oncol Rep. 1999 Sep-Oct; 6(5):1097-9. PMID: 10425308.
label Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

Highlights
Search Criteria
  • Melanoma
  • therapeutics